                </a></li></ul></div><p><strong>Figure 6.  <span>PA-Av-C3d<sub>3</sub> provides enhanced protection against aerosol anthrax spore challenge.</span></strong></p><a id="article1.body1.sec3.sec6.fig1.caption1.p1" name="article1.body1.sec3.sec6.fig1.caption1.p1"></a><p>A/J mice were immunized with either: adjuvant control (*), PA-Av/IFA (○), PA-Av-Alum (□), or PA-Av-C3d<sub>3</sub>/IFA (▵). Ten days after immunization, mice were challenged with (A) 5×10<sup>5</sup> (10–40x LD<sub>50</sub>, n = 5 per group) or (B) 5×10<sup>6</sup> (100–400×LD<sub>50,</sub> n = 10 per group) Sterne <em>B. anthracis</em> spores administered intranasally. Mouse survival was monitored for 10 days post-spore challenge.</p>
<span>THISISTHEEND
